{
    "clinical_study": {
        "@rank": "107395", 
        "arm_group": {
            "arm_group_label": "Use of ECMO in non-intubated patients", 
            "arm_group_type": "Experimental", 
            "description": "ECMO will be used in non-intubated patients with ARDS"
        }, 
        "brief_summary": {
            "textblock": "Proof-of-concept study addressing the feasibility of awake ECMO (v/v) in patients with acute\n      respiratory failure"
        }, 
        "brief_title": "Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)", 
        "condition": "ARDS", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Newborn", 
                "Respiratory Distress Syndrome, Adult", 
                "Acute Lung Injury"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged 18-75 yrs with acute respiratory failure due to ARDS or pneumonia\n             fulfilling standard criteria for endotracheal intubation\n\n               -  Severe and progressive hypoxemia, i.e. PaO2  < 60 mmHg or SaO2 < 90% on O2 > 10\n                  l/min not tolerating noninvasive ventilation, or\n\n               -  PaO2/FiO2 < 200 not improving or deteriorating on noninvasive ventilation, or\n\n               -  Respiratory distress and hypoxemia not fulfilling the criteria above with\n                  clinical impression of the ICU attending that intubation and mechanical\n                  ventilation are mandated\n\n          -  Patient considered eligible by at least two investigators of this study\n\n        Exclusion Criteria:\n\n          -  Patient does not fulfill the inclusion criteria\n\n          -  Uncontrolled malignancy\n\n          -  Severe and untreatable coagulation or bleeding disorders (INR > 2,0; aPTT > 60s,\n             Platelet count < 50.000/\u00b5l, all after substitution)\n\n          -  Stroke within the past 3 months\n\n          -  Uncontrolled sepsis or septic shock\n\n          -  Multiorgan failure involving > 2 organ systems\n\n          -  Norepinephrine dose > 1 mg/h\n\n          -  Hyperdynamic circulation, indicated by cardiac index > 4.0 l/min/m2 (measured by\n             PiCCO or Swan-Ganz catheter), or SvO2 > 80%\n\n          -  Cardiac pump failure, indicated by echocardiography (EF < 40%), PiCCO or Swan Ganz\n             catheter (CI < 2,5 l/min/m2 despite adequate volume management), or SvO2 < 50%\n             (provided Hb > 9,0 g/dl and SaO2 > 90%), or the need for inotropes (dobutamine,\n             epinephrine, levosimendan)\n\n          -  Clinical or echocardiographic signs of pulmonary hypertension with right ventricular\n             dysfunction\n\n          -  APACHE-II score15 < 25\n\n          -  Other conditions suggesting that the patient would benefit from intubation and\n             mechanical ventilation\n\n          -  Severe neurological disorders\n\n          -  Estimated mortality due to severity of acute and/or underlying illness > 50%"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669863", 
            "org_study_id": "MHH-6208"
        }, 
        "intervention": [
            {
                "arm_group_label": "Use of ECMO in non-intubated patients", 
                "intervention_name": "ECMO", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Use of ECMO in non-intubated patients", 
                "intervention_name": "ECMO in non-intubated patients", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "ARDS", 
        "lastchanged_date": "March 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hannover", 
                    "country": "Germany", 
                    "zip": "30625"
                }, 
                "name": "Hannover Medical School"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Awake Extracorporeal Membrane Oxygenation (ECMO) for Acute Respiratory Failure A Non-controlled, Single-center, Investigator-initiated Prove-of-concept Study", 
        "other_outcome": {
            "description": "regular assessment during ICU stay", 
            "measure": "Oxygenation index", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "overall_official": {
            "affiliation": "Hannover Medical School", 
            "last_name": "Marius M Hoeper, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics committee Hannover Medical School", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "-\tN=6 patients will be enrolled in this exploratory pilot trial; if endotracheal intubation can be avoided in 2 or more of these patients, the trial will be considered positive. In that case, the next step would be a larger trial to better define the patient population with the highest likelihood of responding to this new therapeutic concept.", 
            "measure": "Prevention of endotrachael intubation", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669863"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hannover Medical School", 
            "investigator_full_name": "Marius Hoeper, MD", 
            "investigator_title": "Principle Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "ECMO-related complications", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "source": "Hannover Medical School", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hannover Medical School", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}